GR

Gulgunji Ramachandra Bhat

Director Director DIN 01293851
DIN 01293851 First appointment Feb 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Feb 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Gulgunji Ramachandra Bhat

Data last updated:

Gulgunji Ramachandra Bhat has 18 years in corporate governance. Formerly with 1 company, such as Stemcyte India Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01293851
Primary Designation Director
First Appointment 08 Feb 2008
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Feb 20082008₹15.53 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Stemcyte India Therapeutics Private Limited
Premium access

Shareholding and investment profile for Gulgunji Ramachandra Bhat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gulgunji Ramachandra Bhat

Gulgunji Ramachandra Bhat has 18 years in corporate governance. Formerly with 1 company, such as Stemcyte India Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations.

Gulgunji Ramachandra Bhat has expertise in General Business.

Gulgunji Ramachandra Bhat has 18 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available